RU2018123791A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2018123791A3 RU2018123791A3 RU2018123791A RU2018123791A RU2018123791A3 RU 2018123791 A3 RU2018123791 A3 RU 2018123791A3 RU 2018123791 A RU2018123791 A RU 2018123791A RU 2018123791 A RU2018123791 A RU 2018123791A RU 2018123791 A3 RU2018123791 A3 RU 2018123791A3
- Authority
- RU
- Russia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/316—Foods, ingredients or supplements having a functional effect on health having an effect on regeneration or building of ligaments or muscles
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Mycology (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1522892.7A GB201522892D0 (en) | 2015-12-24 | 2015-12-24 | Compositions |
| GB1522892.7 | 2015-12-24 | ||
| GB1611960.4 | 2016-07-08 | ||
| GBGB1611960.4A GB201611960D0 (en) | 2016-07-08 | 2016-07-08 | Compositions |
| PCT/EP2016/082596 WO2017109195A1 (en) | 2015-12-24 | 2016-12-23 | Compositions comprising nicotinamide riboside and a urolithin |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2018123791A RU2018123791A (ru) | 2020-01-24 |
| RU2018123791A3 true RU2018123791A3 (ru) | 2020-04-08 |
| RU2751638C2 RU2751638C2 (ru) | 2021-07-15 |
Family
ID=57614386
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2018123791A RU2751638C2 (ru) | 2015-12-24 | 2016-12-23 | Композиции, содержащие никотинамидрибозид и уролитин |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11166972B2 (ru) |
| EP (1) | EP3393467B1 (ru) |
| JP (1) | JP7182837B2 (ru) |
| CN (1) | CN108778269B (ru) |
| AU (1) | AU2016375177B2 (ru) |
| CA (1) | CA3009432A1 (ru) |
| ES (1) | ES2832506T3 (ru) |
| RU (1) | RU2751638C2 (ru) |
| WO (1) | WO2017109195A1 (ru) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2013284419A1 (en) | 2012-06-27 | 2015-02-12 | Amazentis Sa | Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof |
| CN108778269B (zh) | 2015-12-24 | 2021-06-18 | 阿马曾提斯公司 | 包含烟碱酰胺核糖苷和尿石素的组合物 |
| EP3642214A2 (en) | 2017-06-19 | 2020-04-29 | Gangadhara Ganapati | Nicotinamide riboside derivatives and their uses |
| US20210186996A1 (en) * | 2017-12-01 | 2021-06-24 | Elysium Health, Inc. | Methods and compositions for treating multiple sclerosis |
| WO2019133815A1 (en) | 2017-12-28 | 2019-07-04 | Kansas State University Research Foundation | Nicotinamide riboside treatments of domesticated meat animals |
| US11815515B2 (en) | 2018-01-17 | 2023-11-14 | University Of Southampton | Methods to predict risk of and to stratify sarcopenia and NAD deficiency |
| US20210267932A1 (en) | 2018-05-15 | 2021-09-02 | University Of Louisville Research Foundation, Inc. | Compounds, compositions, methods of using, and methods for preparing compounds |
| AU2019290925B9 (en) * | 2018-06-21 | 2025-08-21 | Societe Des Produits Nestle S.A. | Compositions and methods using a nicotinamide adenine dinucleotide (NAD+) precursor and at least one ketone or ketone precursor |
| AU2019346007B2 (en) * | 2018-09-27 | 2025-08-14 | Société des Produits Nestlé S.A. | Compositions and methods using at least one glycine or derivative thereof, at least one N-acetylcysteine or derivative thereof, and at least one nicotinamide riboside or NAD+ precursor |
| WO2020131578A2 (en) | 2018-12-17 | 2020-06-25 | Mitopower Llc | Nicotinyl riboside compounds and their uses |
| CN113260360A (zh) * | 2019-01-18 | 2021-08-13 | 雀巢产品有限公司 | 用于增加干细胞功能的试剂和方法 |
| WO2020201076A2 (en) * | 2019-03-29 | 2020-10-08 | Société des Produits Nestlé S.A. | Compositions and methods for increasing t cell function |
| US20200397807A1 (en) * | 2019-06-18 | 2020-12-24 | MitoPower, LLC | Nicotinyl riboside compounds and their uses |
| EP4034133A1 (en) * | 2019-09-25 | 2022-08-03 | Société des Produits Nestlé S.A. | Compositions and methods using adenosylcobalamin |
| US20220370511A1 (en) * | 2019-11-05 | 2022-11-24 | Myos Corp. | Methods and compositions for enhancing overall health and longevity in mammals |
| CN116234900A (zh) * | 2020-09-28 | 2023-06-06 | 雀巢产品有限公司 | 用于增加干细胞功能的组合物和方法 |
| AU2021350472A1 (en) * | 2020-09-28 | 2023-03-02 | Ludwig Institute For Cancer Research | Compositions and methods for increasing stem cell function |
| JP2023548905A (ja) * | 2020-11-18 | 2023-11-21 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | 細胞エネルギーのための、オレウロペイン及びニコチンアミドリボシドの組み合わせを使用する組成物及び方法 |
| CN112500445B (zh) * | 2020-12-04 | 2022-11-29 | 黄冈鲁班药业股份有限公司 | β-烟酰胺核糖的制备方法 |
| CA3206062A1 (en) | 2021-01-27 | 2022-08-04 | Said Oumouch | Urolithin derivatives and methods of use thereof |
| GB202107957D0 (en) * | 2021-06-03 | 2021-07-21 | Mitocholine Ltd | Nutritional compositions for skeletal muscle |
| GB202112170D0 (en) * | 2021-08-25 | 2021-10-06 | Mitocholine Ltd | Nutritional compositions |
| BE1029965B1 (nl) * | 2021-11-26 | 2023-06-27 | Dormouse Bv | Anti-verouderingssupplement |
| EP4356757A1 (en) | 2022-10-18 | 2024-04-24 | Consejo Superior de Investigaciones Científicas (CSIC) | Microbial method for reproducing the human urolithin metabotypes in vitro and in vivo |
| EP4400102A1 (en) * | 2023-01-12 | 2024-07-17 | Fempharma, LLC | Pharmaceutical composition and method for improving biomechanical integrity of the pelvic floor |
| CN119792272B (zh) * | 2025-02-07 | 2025-10-03 | 陕西中鸿科瑞再生医学研究院有限公司 | 一种改善睡眠的组合物及其制备方法与制剂 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009500357A (ja) | 2005-07-07 | 2009-01-08 | サートリス ファーマシューティカルズ, インコーポレイテッド | 肥満、インスリン抵抗性障害およびミトコンドリア関連障害を処置または予防するための方法および関連する組成物 |
| DK1957086T3 (en) * | 2005-11-18 | 2018-06-06 | Cornell Res Foundation Inc | NICOTINOYL RIBOSIDE COMPOSITIONS AND METHODS OF USE |
| BR112012002183A2 (pt) | 2009-07-24 | 2016-05-31 | Amazentis Sa | compostos, composições e métodos para proteger a saúde do cérebro em transtornos neurodegenerativos |
| PT3372228T (pt) * | 2010-12-23 | 2025-05-26 | Amazentis Sa | Método não-terapêutico de aumento ou manutenção da função mitocondrial |
| AU2013284419A1 (en) * | 2012-06-27 | 2015-02-12 | Amazentis Sa | Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof |
| US20150231164A1 (en) | 2012-09-13 | 2015-08-20 | Morishita Jintan Co., Ltd. | Sirtuin gene potentiator, and pharmaceutical product, cosmetic product, and food product using same |
| CA2895914C (en) | 2013-01-18 | 2023-06-20 | Procell Sprl | Urolithin b with testosterone, leucine and/or creatine for muscle growth |
| GB201323008D0 (en) | 2013-12-24 | 2014-02-12 | Amazentis As | Compounds and uses thereof |
| CN108778269B (zh) | 2015-12-24 | 2021-06-18 | 阿马曾提斯公司 | 包含烟碱酰胺核糖苷和尿石素的组合物 |
-
2016
- 2016-12-23 CN CN201680080000.4A patent/CN108778269B/zh active Active
- 2016-12-23 JP JP2018533612A patent/JP7182837B2/ja active Active
- 2016-12-23 CA CA3009432A patent/CA3009432A1/en active Pending
- 2016-12-23 US US16/064,922 patent/US11166972B2/en active Active
- 2016-12-23 RU RU2018123791A patent/RU2751638C2/ru active
- 2016-12-23 EP EP16819114.6A patent/EP3393467B1/en active Active
- 2016-12-23 ES ES16819114T patent/ES2832506T3/es active Active
- 2016-12-23 WO PCT/EP2016/082596 patent/WO2017109195A1/en not_active Ceased
- 2016-12-23 AU AU2016375177A patent/AU2016375177B2/en active Active
-
2021
- 2021-10-08 US US17/497,392 patent/US12220424B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2016375177A1 (en) | 2018-07-19 |
| JP2019505504A (ja) | 2019-02-28 |
| CN108778269A (zh) | 2018-11-09 |
| RU2751638C2 (ru) | 2021-07-15 |
| CA3009432A1 (en) | 2017-06-29 |
| US12220424B2 (en) | 2025-02-11 |
| WO2017109195A1 (en) | 2017-06-29 |
| US20220105117A1 (en) | 2022-04-07 |
| US20190008883A1 (en) | 2019-01-10 |
| JP7182837B2 (ja) | 2022-12-05 |
| CN108778269B (zh) | 2021-06-18 |
| EP3393467B1 (en) | 2020-07-01 |
| ES2832506T3 (es) | 2021-06-10 |
| EP3393467A1 (en) | 2018-10-31 |
| US11166972B2 (en) | 2021-11-09 |
| RU2018123791A (ru) | 2020-01-24 |
| AU2016375177B2 (en) | 2022-09-01 |